CVS and Walgreens are poised to vaccinate residents and employees of long-term care facilities. Dentists and optometrists are angling to be among the healthcare professionals who could administer the COVID-19 vaccines.
With approval of the Pfizer-BioNTech COVID-19 happening as early as next week, attention is shifting how it and other COVID-19 vaccines will be distributed and administered.
Certainly pharmacists and possibly dentists and optometrists will be playing an important role in administering the COVID-19 vaccine. HHS announced in late October that CVS and Walgreens had agreed to administer COVID-19 vaccines to residents of nursing home and other long-term care facilities. The Wall Street Journal reported this week that the two pharmacy chains are on track to deliver most of the vaccine doses to about 15,600 nursing homes and 29,000 assisted-living facilities.
Meanwhile, the CDC’s Advisory Committee on Immunization Practices voted 13-1 on Tuesday to recommend that residents and employees of long-term care facilities be among the first to be vaccinated along with healthcare workers. CDC Director Robert Redfield must accept the committee’s recommendations before it becomes official CDC policy. But even after that happens, the CDC’s policies are only recommendations; state-level officials decide how to prioritize vaccine. They are expected to follow the CDC’s recommendations, perhaps with some adjustments because of conditions in their states, but they don’t have to.
The FDA’s Vaccines and Related Biological Products Advisory Committee is scheduled to meet next Thursday, December 10, to consider an emergency use authorization for the Pfizer-BioNTech vaccine. Based on the data reported so far, it seems very likely that the committee will vote in favor of the authorization. The New York Times reported this week that federal officials have plans to ship 6.4 million doses within 24 hours of when the FDA approves an emergency use authorization for a vaccine. The Times reported that Pfizer will be shipping its vaccines in special coolers, each containing about 1,000 doses. The coolers are necessary because the Pfizer-BioNTech vaccine must be stored at a temperature of -94 degrees Fahrenheit. The newspaper reported that most of those receiving sites will be at hospitals that can keep the vaccine doses at that temperature or use them up quickly.
Meanwhile, an increasing number of different sorts of healthcare providers are poised to administer the COVID-19 vaccines once they become more broadly available. Kaiser Health News reported this week that professional organizations representing dentists and optometrists in California have been talking to state officials there adding vaccination to their permitted activities. Minnesota and Illinois already have laws on the books that allow dentists to give flu shots to adults, according to the news services, and last year, Oregon became the first state to allow dentists to give any vaccine.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More